{"id":"adefovir-dipivoxil-adefovir","safety":{"commonSideEffects":[{"rate":null,"effect":"Nephrotoxicity / renal dysfunction"},{"rate":null,"effect":"Headache"},{"rate":null,"effect":"Asthenia / fatigue"},{"rate":null,"effect":"Abdominal pain"},{"rate":null,"effect":"Elevated creatinine"}]},"_chembl":null,"_dailymed":{"setId":"08e07fae-3191-b6a3-c894-d3a8cc53923f","title":"ADEFOVIR DIPIVOXIL TABLET [APOTEX CORP.]"},"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Adefovir is a prodrug that is converted to adefovir (an acyclic nucleotide analogue) in cells, where it inhibits hepatitis B virus (HBV) reverse transcriptase and DNA polymerase, preventing viral replication. It is incorporated into the growing viral DNA chain, causing chain termination and reducing HBV DNA levels in infected patients.","oneSentence":"Adefovir dipivoxil is a nucleotide reverse transcriptase inhibitor that blocks viral DNA polymerase activity in hepatitis B virus.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T00:59:46.050Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Chronic hepatitis B infection"}]},"trialDetails":[{"nctId":"NCT00059267","phase":"","title":"Prevention of Recurrent Hepatitis B After Liver Transplantation","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2001-03","conditions":"Hepatitis B, Cirrhosis, Acute Liver Failure","enrollment":317},{"nctId":"NCT03736265","phase":"NA","title":"Carvedilol for Prevention of Esophageal Varices Progression","status":"UNKNOWN","sponsor":"Beijing Friendship Hospital","startDate":"2017-10-09","conditions":"Cirrhosis, Liver, Portal Hypertension","enrollment":240},{"nctId":"NCT00307242","phase":"PHASE4","title":"Study Comparing the Safety of Switching From Lamivudine to Adefovir Dipivoxil Versus Overlapping Lamivudine and Adefovir Before Adefovir Dipivoxil Monotherapy in Patients With Chronic Hepatitis B","status":"COMPLETED","sponsor":"Thomas Jefferson University","startDate":"2005-06-17","conditions":"Chronic Hepatitis B","enrollment":40},{"nctId":"NCT00000892","phase":"NA","title":"A Study of Several Anti-HIV Drug Combinations in HIV-Infected Patients Who Have Used Indinavir","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":300},{"nctId":"NCT00051077","phase":"PHASE2","title":"Treatment of Hepatitis in Patients Who Are Triple-Infected With HIV, Hepatitis B Virus (HBV), and Hepatitis C Virus (HCV)","status":"WITHDRAWN","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections, Hepatitis B, Hepatitis C","enrollment":""},{"nctId":"NCT00033163","phase":"PHASE2","title":"A Comparison of Adefovir and Tenofovir for the Treatment of Lamivudine-Resistant Hepatitis B Virus in People With HIV","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections, Hepatitis B","enrollment":90},{"nctId":"NCT00001087","phase":"PHASE2","title":"The Effectiveness of Nelfinavir and Efavirenz, Used Alone or Together, Combined With Other Anti-HIV Drugs in Patients Who Have Taken Anti-HIV Drugs","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":300},{"nctId":"NCT00000912","phase":"PHASE2","title":"A Study on Amprenavir in Combination With Other Anti-HIV Drugs in HIV-Positive Patients","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":475},{"nctId":"NCT00000885","phase":"PHASE2","title":"Treatment Success and Failure in HIV-Infected Subjects Receiving Indinavir in Combination With Nucleoside Analogs: A Rollover Study for ACTG 320","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":440},{"nctId":"NCT05021406","phase":"NA","title":"Extension Study of Carvedilol RCT Study","status":"UNKNOWN","sponsor":"Beijing Friendship Hospital","startDate":"2021-01-08","conditions":"Liver Cirrhosis, Portal Hypertension","enrollment":240},{"nctId":"NCT01146808","phase":"PHASE1, PHASE2","title":"Adefovir Plus Vaccination in Transplant Patients Without Hepatitis B That Receive a Core Antibody Positive Liver","status":"COMPLETED","sponsor":"Columbia University","startDate":"2006-03","conditions":"Hepatitis B, Liver Transplantation","enrollment":16},{"nctId":"NCT04724785","phase":"","title":"Real World Study About Anti-viral Regimen Adjustment on Achieving Complete Response in CHB Patients","status":"UNKNOWN","sponsor":"The Second Affiliated Hospital of Chongqing Medical University","startDate":"2020-12-01","conditions":"Sustained Virologic Response, Hepatitis B, Chronic","enrollment":10000},{"nctId":"NCT03366571","phase":"","title":"Improvement of Hard Endpoint in Chronic Hepatitis B Patients Treated With Antiviral Therapy","status":"UNKNOWN","sponsor":"Beijing Friendship Hospital","startDate":"2016-01","conditions":"Chronic Hepatitis B","enrollment":600},{"nctId":"NCT00973219","phase":"NA","title":"Hepatitis B Surface Antigen(HBsAg) Loss in Chronic Hepatitis B Patients With Low Viral Load","status":"COMPLETED","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2009-09","conditions":"Chronic Hepatitis B","enrollment":151},{"nctId":"NCT01373684","phase":"PHASE4","title":"PEG-interferon Alfa-2a add-on Study in HBeAg Negative Chronic Hepatitis B Patients","status":"COMPLETED","sponsor":"Foundation for Liver Research","startDate":"2012-05-25","conditions":"Chronic Hepatitis B","enrollment":90},{"nctId":"NCT02743260","phase":"PHASE4","title":"Drug Transporter Interaction Study PHENTRA_2015_KPUK","status":"COMPLETED","sponsor":"University of Cologne","startDate":"2016-04","conditions":"Healthy","enrollment":24},{"nctId":"NCT01300234","phase":"PHASE3","title":"Efficacy and Safety of Tenofovir Disoproxil Fumarate (TDF) 300mg in Chinese Subjects With Chronic Hepatitis B (CHB)","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2011-03-30","conditions":"Hepatitis B","enrollment":512},{"nctId":"NCT01205165","phase":"PHASE4","title":"An Open Label, Multi Centre Phase IV Study of Adefovir Dipivoxil in Korean Patients With Chronic Hepatitis B (CHB)","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2004-12-17","conditions":"Hepatitis B, Chronic","enrollment":104},{"nctId":"NCT01521975","phase":"PHASE4","title":"A Two-year Study of Telbivudine in HBeAg Negative Hepatitis","status":"COMPLETED","sponsor":"Third Affiliated Hospital, Sun Yat-Sen University","startDate":"2011-01-01","conditions":"Hepatitis B, Chronic","enrollment":360},{"nctId":"NCT01353742","phase":"PHASE1","title":"Lamivudine and Adefovir Dipivoxil Fixed Dose Combination","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2011-02-21","conditions":"Hepatitis B, Chronic","enrollment":40},{"nctId":"NCT01329419","phase":"","title":"HEPSERA Post Marketing Surveillance","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2004-08","conditions":"Hepatitis B","enrollment":4393},{"nctId":"NCT00455091","phase":"","title":"A Phase III Study in Post-operative HBV-related Hepatocellular Carcinoma","status":"TERMINATED","sponsor":"National Health Research Institutes, Taiwan","startDate":"2007-05","conditions":"Hepatocellular Carcinoma","enrollment":117},{"nctId":"NCT00371761","phase":"PHASE3","title":"PegIntron Versus Adefovir in the Treatment of Chronic Hepatitis B (CHB) e Antigen Positive Patients in Taiwan (P04498/MK-4031-278)","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"2006-09","conditions":"Hepatitis B, Chronic (CHB)","enrollment":25},{"nctId":"NCT00640588","phase":"PHASE3","title":"Prospective Exploratory Study to Describe Hepatitis B Virus (HBV) Kinetics During Treatment With Telbivudine","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2008-03","conditions":"Hepatitis B, Chronic","enrollment":30},{"nctId":"NCT00116805","phase":"PHASE3","title":"A Study to Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Positive Chronic Hepatitis B","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"2005-06","conditions":"Chronic Hepatitis B","enrollment":266},{"nctId":"NCT00117676","phase":"PHASE3","title":"A Study to Compare Tenofovir Disoproxil Fumarate Versus Adefovir Dipivoxil for the Treatment of HBeAg-Negative Chronic Hepatitis B","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"2005-02","conditions":"Chronic Hepatitis B","enrollment":382},{"nctId":"NCT02965859","phase":"PHASE2","title":"The Safety and Dose-range Study of Metacavir Enteric-coated Capsules in Patients With Chronic Hepatitis B","status":"UNKNOWN","sponsor":"Guangzhou Yipinhong Pharmaceutical CO.,LTD","startDate":"2012-12","conditions":"Chronic Hepatitis B","enrollment":180},{"nctId":"NCT00661076","phase":"PHASE3","title":"ADVANCE Study: A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) + Adefovir Dipivoxil in Patients With Hbe(-) Chronic Hepatitis B","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2008-08","conditions":"Hepatitis B, Chronic","enrollment":10},{"nctId":"NCT01732367","phase":"PHASE4","title":"TDF VS LAM + ADV in LAM + ADV Treated LAM-resistant CHB Patients With Undetectable Hepatitis B Virus DNA","status":"COMPLETED","sponsor":"Keimyung University Dongsan Medical Center","startDate":"2012-11","conditions":"Chronic Hepatitis B","enrollment":171},{"nctId":"NCT00023309","phase":"PHASE2","title":"Lamivudine and Adefovir to Treat Chronic Hepatitis B","status":"COMPLETED","sponsor":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","startDate":"2001-08","conditions":"HBV (Hepatitis B Virus), Hepatitis B, Hepatitis","enrollment":41},{"nctId":"NCT02327416","phase":"PHASE3","title":"A Prospective Clinical Trial in Chronic Hepatitis B Patients NAs (Nucleotides or Nucleosides) Experienced (Anchor Study)","status":"UNKNOWN","sponsor":"Tongji Hospital","startDate":"2014-10","conditions":"Hepatitis B, Chronic","enrollment":300},{"nctId":"NCT02826070","phase":"PHASE4","title":"EFFORT Further Extension Study","status":"UNKNOWN","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2015-04","conditions":"Hepatitis B, Chronic","enrollment":130},{"nctId":"NCT01491295","phase":"PHASE4","title":"Switch to Tenofovir Versus Continue Lamivudine/Adefovir Treatment in Lamivudine-resistance Chronic Hepatitis B Patients","status":"UNKNOWN","sponsor":"Taipei Veterans General Hospital, Taiwan","startDate":"2012-09","conditions":"Chronic Hepatitis B","enrollment":160},{"nctId":"NCT02598063","phase":"PHASE4","title":"A Study to Evaluate Efficacy and Safety of Peginterferon Alfa-2a (Pegasys) and Adeforvir Dipivoxil (ADV) in Participants With Lamivudine-Resistant Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B","status":"COMPLETED","sponsor":"Hoffmann-La Roche","startDate":"2005-10","conditions":"Hepatitis B, Chronic","enrollment":255},{"nctId":"NCT02560649","phase":"PHASE4","title":"An Exploratory Study of RGT Strategy on Optimal NUC-experienced Patients","status":"UNKNOWN","sponsor":"Ruijin Hospital","startDate":"2015-05","conditions":"Chronic Hepatitis B","enrollment":324},{"nctId":"NCT00986778","phase":"PHASE4","title":"Entecavir Plus Adefovir in Lamivudine-Resistant Patients","status":"WITHDRAWN","sponsor":"Bristol-Myers Squibb","startDate":"2009-12","conditions":"Hepatitis B, Chronic","enrollment":""},{"nctId":"NCT01720238","phase":"","title":"Clinical Effects and Cost-effectiveness Analysis of Early Anti-viral Therapy on HBV-related Compensated Liver Cirrhosis","status":"UNKNOWN","sponsor":"Beijing Friendship Hospital","startDate":"2012-03","conditions":"Liver Cirrhosis, Hepatitis B","enrollment":621},{"nctId":"NCT00115245","phase":"PHASE3","title":"Telbivudine Versus Adefovir Dipivoxil in Adults With HBegAg-Positive, Compensated Chronic Hepatitis B","status":"COMPLETED","sponsor":"Novartis","startDate":"2004-11","conditions":"Chronic Hepatitis B","enrollment":""},{"nctId":"NCT02327663","phase":"PHASE4","title":"Emtricitabine for Naive Chinese Chronic Hepatitis B Patients","status":"UNKNOWN","sponsor":"Asian-Pacific Alliance of Liver Disease, Beijing","startDate":"2014-12","conditions":"Hepatitis B, Chronic","enrollment":2000},{"nctId":"NCT02327689","phase":"PHASE4","title":"Emtricitabine Plus Adefovir Dipivoxil for Naive Chinese HBV Related Cirrhosis Patients","status":"UNKNOWN","sponsor":"Asian-Pacific Alliance of Liver Disease, Beijing","startDate":"2015-01","conditions":"Hepatitis B, Chronic, Fibrosis","enrollment":400},{"nctId":"NCT00672867","phase":"PHASE3","title":"A Pilot Study to Evaluate the Safety and Efficacy of Clevudine or Adefovir Patients With LC-B","status":"COMPLETED","sponsor":"Bukwang Pharmaceutical","startDate":"2007-12","conditions":"Patients With LC-B","enrollment":102},{"nctId":"NCT01264354","phase":"PHASE4","title":"An Open Study to Evaluate the Efficacy, Safety of Clevudine Monotherapy or Adefovir and Clevudine Combination in Patients With Chronic Hepatitis B","status":"COMPLETED","sponsor":"Bukwang Pharmaceutical","startDate":"2010-03","conditions":"Chronic Hepatitis B","enrollment":60},{"nctId":"NCT02075294","phase":"","title":"Efficacy and Safety Study of Adefovir and Entecavir for Elderly With Chronic Hepatitis B","status":"COMPLETED","sponsor":"Ying-Jie Ji","startDate":"2010-01","conditions":"Hepatitis B, Chronic","enrollment":242},{"nctId":"NCT01023217","phase":"PHASE4","title":"Entecavir Plus Adefovir in Lamivudine-Resistant Chronic Hepatitis B Patients Who Fail Lamivudine Plus Adefovir","status":"COMPLETED","sponsor":"Asan Medical Center","startDate":"2009-11","conditions":"Hepatitis B, Chronic","enrollment":90},{"nctId":"NCT01597934","phase":"PHASE4","title":"Antiviral Efficacy of Switching to ETV Plus TDF","status":"UNKNOWN","sponsor":"Yonsei University","startDate":"2012-08","conditions":"Chronic Hepatitis B","enrollment":104},{"nctId":"NCT00158717","phase":"","title":"Observational Study of the Durability of Seroconversion Chronic HBV Patients Who Seroconverted in a Previous Gilead-Sponsored Study of ADV.","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"2003-04","conditions":"Hepatitis B","enrollment":107},{"nctId":"NCT00042393","phase":"","title":"An Open-Label Program of Adefovir Dipivoxil in the Treatment of Patients With Lamivudine-Resistant Chronic Hepatitis B With Limited Treatment Options","status":"APPROVED_FOR_MARKETING","sponsor":"Gilead Sciences","startDate":"","conditions":"Chronic Hepatitis B","enrollment":""},{"nctId":"NCT00410202","phase":"PHASE3","title":"Entecavir Plus Adefovir Combination Therapy Versus Entecavir Monotherapy vs Therapy With Adefovir Plus Lamivudine for Chronic Hepatitis B Infected Subjects With Lamivudine-resistant Virus","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2008-03","conditions":"Hepatitis B, Chronic","enrollment":629},{"nctId":"NCT00071201","phase":"PHASE3","title":"Evaluate Efficacy, Safety and PK of Adefovir Dipivoxil Liquid Suspension in Patients With Chronic Hepatitis B","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"2003-06","conditions":"Chronic Hepatitis B","enrollment":48},{"nctId":"NCT00001082","phase":"PHASE3","title":"The Safety and Effectiveness of Adefovir Dipivoxil in the Treatment of HIV-Infected Patients","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"1996-12","conditions":"Cytomegalovirus Infections, HIV Infections","enrollment":505},{"nctId":"NCT01844063","phase":"PHASE1, PHASE2","title":"Safety and Efficacy of Diverse Mesenchymal Stem Cells Transplantation for Liver Failure","status":"UNKNOWN","sponsor":"Third Affiliated Hospital, Sun Yat-Sen University","startDate":"2013-07","conditions":"Liver Failure","enrollment":210},{"nctId":"NCT00199732","phase":"","title":"Evaluation of cccDNA and Total HBV DNA Kinetics in Lymphocytes, Total Blood and Serum in Chronic Hepatitis B Patients Treated With Adefovir Dipivoxil and Peg Interferon Alpha 2a","status":"COMPLETED","sponsor":"University Hospital, Limoges","startDate":"2004-12","conditions":"Chronic Hepatitis B","enrollment":19},{"nctId":"NCT01804387","phase":"PHASE4","title":"Comparison of Telbivudine Plus Adefovir With Lamivudine Plus Adefovir for the Treatment of Lamivudine-resistant Chronic Hepatitis B at 52 Weeks: A Pilot Study","status":"UNKNOWN","sponsor":"Korea University","startDate":"2011-05","conditions":"Chronic Hepatitis B","enrollment":60},{"nctId":"NCT00187746","phase":"PHASE4","title":"Effect of Age on the Renal Clearance of Adefovir","status":"WITHDRAWN","sponsor":"University of California, San Francisco","startDate":"2005-08","conditions":"Other Conditions That May Be A Focus of Clinical Attention","enrollment":""},{"nctId":"NCT01718587","phase":"PHASE1, PHASE2","title":"Difference in Efficacy Between Stem Cell Transplantation and Classical Therapy in Liver Cirrhosis Patients","status":"UNKNOWN","sponsor":"General Hospital of Chinese Armed Police Forces","startDate":"2012-11","conditions":"Liver Cirrhosis","enrollment":60},{"nctId":"NCT00531167","phase":"PHASE4","title":"Adding Adefovir Dipivoxil Versus Switching to Entecavir in Patients With Lamivudine-resistant Chronic Hepatitis B","status":"COMPLETED","sponsor":"Korea University","startDate":"2007-04","conditions":"Chronic Hepatitis B","enrollment":219},{"nctId":"NCT01581242","phase":"PHASE1","title":"A Clinical Trial to Investigate the Pharmacokinetic Drug-drug Interaction of Clevudine and Adefovir Dipivoxil After Oral Administration in Healthy Male Subjects","status":"COMPLETED","sponsor":"Bukwang Pharmaceutical","startDate":"2012-04","conditions":"Healthy","enrollment":42},{"nctId":"NCT00513968","phase":"PHASE1","title":"Phase I Study to Investigate the Safety and Efficacy of HBV DNA Vaccine","status":"COMPLETED","sponsor":"Genexine, Inc.","startDate":"2007-07","conditions":"Chronic Hepatitis B","enrollment":27},{"nctId":"NCT00347009","phase":"PHASE4","title":"Adefovir Dipivoxil For The Treatment Of Patients With Chronic Hepatitis B Related Advanced Fibrosis Or Cirrhosis","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2005-05","conditions":"Hepatitis B, Chronic, Cirrhosis, Fibrosis","enrollment":155},{"nctId":"NCT00095121","phase":"PHASE3","title":"Safety and Efficacy of Adefovir Dipivoxil in Children and Adolescents With Chronic Hepatitis B","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"2004-06","conditions":"Chronic Hepatitis B","enrollment":173},{"nctId":"NCT00606099","phase":"PHASE4","title":"Efficacy and Safety of Telbivudine in Patients With Chronic Hepatitis B","status":"WITHDRAWN","sponsor":"Novartis","startDate":"2007-11","conditions":"Chronic Hepatitis B","enrollment":""},{"nctId":"NCT00641082","phase":"PHASE4","title":"A Double-Blind Randomized Clinical Trial Comparing the Safety and Antiviral Activity of 48-week Clevudine and Adefovir Dipivoxil in HBeAg(-) Chronic Hepatitis B With Compensated Liver Function","status":"COMPLETED","sponsor":"Bukwang Pharmaceutical","startDate":"2008-02","conditions":"HBeAg(-) Chronic Hepatitis B With Compensated Liver Function","enrollment":43},{"nctId":"NCT00715715","phase":"NA","title":"Efficacy Study of Prednisone Priming to Treat Asian Chronic Hepatitis B Patients","status":"WITHDRAWN","sponsor":"Maimonides Medical Center","startDate":"2008-04","conditions":"Chronic Hepatitis B","enrollment":""},{"nctId":"NCT00307489","phase":"PHASE2","title":"Treatment of Persistent Viremia (Virus in Blood) in Chronic Hepatitis B Subjects Already Receiving Adefovir Dipivoxil","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"2006-03","conditions":"Chronic Hepatitis B","enrollment":106},{"nctId":"NCT01436539","phase":"PHASE4","title":"Study of Effects and Safety Between Adefovir Dipivoxil Plus Polyene Phosphatidylcholine Versus Adefovir Dipivoxil Alone in Chronic Hepatitis B Patients","status":"UNKNOWN","sponsor":"Jun Cheng","startDate":"2011-09","conditions":"Chronic Hepatitis B","enrollment":300},{"nctId":"NCT00376259","phase":"PHASE3","title":"Study of Combination Therapy With LdT Plus Adefovir Versus Adefovir Alone","status":"TERMINATED","sponsor":"Novartis","startDate":"2007-01","conditions":"Hepatitis B","enrollment":43},{"nctId":"NCT00798460","phase":"PHASE4","title":"Efficacy of Clevudine Plus Lamivudine for Lamivudine-resistant Chronic Hepatitis B Patients","status":"TERMINATED","sponsor":"Inje University","startDate":"2008-12","conditions":"Chronic Hepatitis B","enrollment":30},{"nctId":"NCT00403585","phase":"PHASE4","title":"Study of Adefovir Dipivoxil for Korean Patients With Chronic Hepatitis B(CHB) Who Have Completed ADF 103814","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-07","conditions":"Hepatitis B, Chronic, Chronic Hepatitis B","enrollment":80},{"nctId":"NCT00753467","phase":"PHASE2","title":"A Phase II Study to Determine the Safety and Efficacy of Interferon-gamma in Patients With Chronic Hepatitis B","status":"UNKNOWN","sponsor":"Huntington Medical Research Institutes","startDate":"2008-09","conditions":"Hepatitis B","enrollment":30},{"nctId":"NCT00489151","phase":"NA","title":"A Randomized Study Comparing Lamivudine Versus Adefovir Dipivoxil for Prevention of zHBV Reactivation in HBsAg Seropositive Patients Undergoing Cytotoxic Chemotherapy","status":"UNKNOWN","sponsor":"Hospital Authority, Hong Kong","startDate":"2005-06","conditions":"Hepatitis B","enrollment":70},{"nctId":"NCT00324961","phase":"PHASE4","title":"Adefovir Dipivoxil Tablets (10mg) In Chinese Subjects With HBe Antigen Negative Chronic Hepatitis B","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-01","conditions":"Chronic Hepatitis B","enrollment":533},{"nctId":"NCT00441974","phase":"PHASE4","title":"Adefovir Dipivoxil For The Treatment Of Chinese Compensated Chronic Hepatitis B(CHB)Patients","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-12","conditions":"Chronic Hepatitis B","enrollment":1470},{"nctId":"NCT00316719","phase":"PHASE3","title":"Adefovir Dipivoxil In Compensated Chronic Hepatitis B Patients","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2006-01","conditions":"Chronic Hepatitis B","enrollment":105},{"nctId":"NCT00895596","phase":"PHASE1, PHASE2","title":"Safety and Efficacy Study of LB80380 in the Patients With Lamivudine-Refractory Chronic Hepatitis B","status":"COMPLETED","sponsor":"LG Life Sciences","startDate":"2004-03","conditions":"Chronic Hepatitis B","enrollment":65},{"nctId":"NCT00857675","phase":"PHASE3","title":"A Efficacy and Safety Study of Adefovir Dipivoxil to Treat Chinese Patients With HBeAg+ve Chronic Hepatitis B","status":"COMPLETED","sponsor":"GlaxoSmithKline","startDate":"2002-12","conditions":"Chronic Hepatitis B","enrollment":480},{"nctId":"NCT00810524","phase":"PHASE4","title":"Influence of Antiviral Treatment to the Long-Term Prognosis of Patients With Chronic HBV Infection","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2007-01","conditions":"Hepatitis B, Chronic","enrollment":600},{"nctId":"NCT00644761","phase":"PHASE2","title":"PK Study of Tacrolimus and Cyclosporine When Co-Administered With Adefovir Dipivoxil in Post-Liver Transplant Patients","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"2004-02","conditions":"Hepatitis B","enrollment":16},{"nctId":"NCT00645294","phase":"PHASE1, PHASE2","title":"Open Label Study of Pharmacokinetics and Safety of Dose of Adefovir Dipivoxil in Children and Adolescents With HBV","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"2003-02","conditions":"Hepatitis B","enrollment":47},{"nctId":"NCT00013702","phase":"PHASE2","title":"Adefovir Dipivoxil to Treat Hepatitis B in HIV-Infected Patients","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2001-03","conditions":"Hepatitis B, HIV Infection","enrollment":30},{"nctId":"NCT00023153","phase":"PHASE3","title":"Lamivudine and Adefovir to Treat Chronic Hepatitis B Infection in People With and Without HIV Infection","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2001-08","conditions":"HIV Infections, Chronic Hepatitis B","enrollment":100},{"nctId":"NCT00230477","phase":"PHASE4","title":"Hepsera Versus Hepsera Plus Lamivudine for Treatment of Chronic Hepatitis B in Patients With Normal ALT","status":"COMPLETED","sponsor":"University of Washington","startDate":"2003-04","conditions":"Hepatitis B","enrollment":19},{"nctId":"NCT00158704","phase":"NA","title":"Continued Access Study of Adefovir Dipivoxil (ADV) for Patients w/Chronic HBV Infection.","status":"TERMINATED","sponsor":"Gilead Sciences","startDate":"2002-01","conditions":"Hepatitis B","enrollment":400},{"nctId":"NCT00002234","phase":"PHASE2","title":"Safety and Effectiveness of Giving an Anti-HIV Drug Combination of Adefovir Dipivoxil Plus Didanosine Plus Efavirenz Plus Lamivudine Once Daily to HIV-Infected Patients","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"","conditions":"HIV Infections","enrollment":25},{"nctId":"NCT00002219","phase":"PHASE2","title":"Safety and Effectiveness of Adding Adefovir Dipivoxil and Nelfinavir to the Anti-HIV Therapy of HIV-Infected Children","status":"UNKNOWN","sponsor":"Gilead Sciences","startDate":"","conditions":"HIV Infections","enrollment":36},{"nctId":"NCT00002379","phase":"PHASE2","title":"The Safety and Effectiveness of Adefovir Dipivoxil Plus Indinavir Combined With Zidovudine or Lamivudine or Stavudine in HIV-Infected Patients Who Have Not Taken Anti-HIV Drugs","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"","conditions":"HIV Infections","enrollment":100},{"nctId":"NCT00002426","phase":"NA","title":"A Study on the Safety and Effectiveness of Adefovir Dipivoxil in Combination With Anti-HIV Therapy (HAART) in HIV-Positive Patients","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"","conditions":"HIV Infections","enrollment":390},{"nctId":"NCT00002419","phase":"PHASE2","title":"Safety and Effectiveness of Giving Adefovir Dipivoxil Plus Abacavir Plus Efavirenz Plus Amprenavir to HIV-Infected Patients Who Have Failed to Respond to Previous Protease Inhibitor Treatment","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"","conditions":"HIV Infections","enrollment":25},{"nctId":"NCT00002161","phase":"NA","title":"A Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Adefovir Dipivoxil When Added to Standard Antiretroviral Therapy for the Treatment of HIV-Infected Patients With CD4 Cell Counts >= 200/mm3","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"","conditions":"HIV Infections","enrollment":400},{"nctId":"NCT00002398","phase":"NA","title":"Safety and Effectiveness of Giving Adefovir (Preveon) Plus Other Anti-HIV Drugs to HIV-Infected Patients Who Have Not Responded to Other Anti-HIV Drug Combinations","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"","conditions":"HIV Infections","enrollment":""},{"nctId":"NCT00002220","phase":"PHASE3","title":"Indinavir Plus Efavirenz Plus Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Had Success With Nelfinavir","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","startDate":"","conditions":"HIV Infections","enrollment":120},{"nctId":"NCT00002128","phase":"PHASE1","title":"Phase I Study of the Safety, Tolerance, and Pharmacokinetics of 9-[2-(Bispivaloyloxymethyl)Phosphonylmethoxyethyl]Adenine (Bis-POM PMEA; Adefovir Dipivoxil) in HIV-Infected Patients","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"","conditions":"HIV Infections","enrollment":15},{"nctId":"NCT00002184","phase":"PHASE2","title":"A Phase II, Stratified, Randomized, Double-Blind, Multi-Center Study of the Safety and Efficacy of Adefovir Dipivoxil (ADF) at Two Dose Levels in Triple Combination Therapies With Protease Inhibitors (PI) and Nucleoside Reverse Transcriptase Inhibitors (RTI) for the Treatment of HIV-Infected Patient","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"","conditions":"HIV Infections","enrollment":120},{"nctId":"NCT00002206","phase":"PHASE1","title":"A Study of Adefovir Dipivoxil in HIV-Infected Patients Who Have Not Been Treated With Anti-HIV Drugs","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"","conditions":"HIV Infections","enrollment":45},{"nctId":"NCT00000843","phase":"PHASE1","title":"The Safety and Effectiveness of Adefovir Dipivoxil in HIV-Infected Children","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections","enrollment":24},{"nctId":"NCT00002346","phase":"PHASE1","title":"The Safety and Effectiveness of Bis-POM PMEA in HIV-Infected Patients","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"","conditions":"HIV Infections","enrollment":36}],"_emaApprovals":[],"_faersSignals":[{"count":3,"reaction":"ALANINE AMINOTRANSFERASE INCREASED"},{"count":3,"reaction":"ASCITES"},{"count":3,"reaction":"ASPARTATE AMINOTRANSFERASE INCREASED"},{"count":3,"reaction":"ATELECTASIS"},{"count":3,"reaction":"HEPATITIS B"},{"count":3,"reaction":"HYPOTENSION"},{"count":2,"reaction":"ANOREXIA"},{"count":2,"reaction":"BILIRUBIN CONJUGATED INCREASED"},{"count":2,"reaction":"BLOOD CREATININE INCREASED"},{"count":2,"reaction":"BLOOD LACTATE DEHYDROGENASE INCREASED"}],"_approvalHistory":[],"publicationCount":1013,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Hepsera"],"phase":"marketed","status":"active","brandName":"Adefovir dipivoxil (adefovir)","genericName":"Adefovir dipivoxil (adefovir)","companyName":"Merck Sharp & Dohme LLC","companyId":"merck","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Adefovir dipivoxil is a nucleotide reverse transcriptase inhibitor that blocks viral DNA polymerase activity in hepatitis B virus. Used for Chronic hepatitis B infection.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}